News | Cardiac Diagnostics | March 04, 2026

Inflo Health Launches New Cardiology Suite

Building on proven radiology success, the care orchestration provider expands into cardiology to advance outcomes across AAA, heart failure and CAC programs

orchestration, cardiology suite, inflo

March 4, 2026 — Inflo Health has launched a comprehensive cardiology suite designed to address care management gaps across three of the most costly and prevalent cardiovascular conditions: abdominal aortic aneurysm (AAA), heart failure and coronary artery calcification (CAC). The expansion represents a step-change evolution of the Inflo platform as an enterprise care orchestration layer, expanding patient management capacity across diagnostic insights.

Cardiology Orchestration

As AI detection algorithms continue to proliferate (most within medical imaging), healthcare faces a pressing new challenge: converting detection into completed care. Nowhere is this gap more acute than in cardiology, where identified findings too often remain disconnected from the care pathways needed to act on them. 

"Every conversation I have with clinical leaders comes back to one question: how do we take all of these diagnostic insights and guide patients to the next step in their care without burning out staff or creating confusion for patients?" said Angela Adams, RN, Chief Executive Officer of Inflo Health. "The systemic problem we solve is that last mile in the care journey. We bring together insights from AI detection and traditional diagnostics into an orchestration layer that works alongside the EHR. Expanding into cardiology is a natural progression as we help providers move patients into care pathways earlier and achieve better outcomes."

Health systems increasingly require an orchestration layer capable of consuming detected findings and guiding patients to the next step in care with clear ownership, timing, escalation pathways, and scalability across specialties. Inflo Health has rapidly addressed this need through a platform designed for universal application across diagnostic insights.

"Cardiology produces a steady stream of clinically meaningful findings. The real risk clinicians face isn't around whether those findings are documented, but whether the next step reliably happens," said Dr. Mahesh Amin, Vice President/Chief Medical Officer for Hospital Service Lines at BayCare Health System. "We partnered with Inflo to develop the capabilities to ensure that patients understand and complete their next step in care. Inflo is not another point solution; it is a platform that helps take us from finding to care delivery."

Three High-Impact Pathways

The new cardiology suite focuses on three distinct orchestration models. AAA management supports structured surveillance and timely escalation. Heart failure workflows enable coordinated follow-up across imaging, cardiology, and care teams. CAC management transforms incidental findings into attributable cardiovascular programs that engage patients earlier in preventive care.

"Two organizational dimensions stand out when thinking about care orchestration," Adams said. "First is attribution—understanding how imaging findings initiate downstream care across service lines. Second is governance. Beyond traditional process and technology oversight, governance must be viewed as a clinical outcome. That perspective is foundational to our high-reliability approach, ensuring transparency and a human-in-the-loop across every care pathway."

Building the Infrastructure 

Rather than adding another specialty tool, Inflo Health is advancing a new category: diagnostic care orchestration. The platform operates as a detection-agnostic layer that ensures findings translate into completed care across the enterprise, regardless of the AI system or imaging modality that surfaced them.

This latest launch comes after years of external validation and client success for Inflo Health. Recognized by the American College of Radiology Learning Network for quality and performance, Inflo Health already has a proven track record: Sentara recently reported a $1.7M return within six months, while East Alabama Medical Center achieved a 74% increase in follow-up closures for incidental lung nodules — outcomes that highlight the growing demand for scalable, high-reliability care orchestration.

As health systems continue investing in AI and advanced diagnostics, the industry is shifting from identifying risk to operationalizing response. By extending beyond radiology into cardiology and additional service lines, Inflo Health is building the infrastructure that connects diagnostic insight to accountable care pathways, enabling organizations to scale clinical impact, improve governance, and realize the full value of their diagnostic investments.

Go to https://inflohealth.com/ to learn more.


Related Content

News | Cardiac Diagnostics

Feb. 26, 2026 — Eko Health has partnered with Wayne General Hospital in Wayne County, Mississippi, to deploy SENSORA, an ...

Home February 26, 2026
Home
News | Cardiac Diagnostics

Nov. 12, 2025 — AISAP, a provider of AI Point-of-Care Diagnostics, has announced a field initiative in Ghana, deploying ...

Home November 12, 2025
Home
News | Cardiac Diagnostics

June 11, 2025 — MorningStar Laboratories, LLC, a developer of precision diagnostic tests that address unmet clinical ...

Home June 16, 2025
Home
News | Cardiac Diagnostics

Aug. 13, 2024 – The traditional lipid panel may not give the full picture of cholesterol-related heart disease risk for ...

Home August 15, 2024
Home
Feature | Cardiac Diagnostics | By Robert L. Quigley, MD, DPhil

Atherosclerotic cardiovascular disease (ASCVD), caused by plaque buildup in arterial walls, is one of the leading causes ...

Home January 23, 2024
Home
News | Cardiac Diagnostics

September 5, 2023 — GE HealthCare announced the launch of a handheld, wireless ultrasound imaging system designed for ...

Home September 05, 2023
Home
Feature | Cardiac Diagnostics | By Kelly Patrick

The global ambulatory diagnostic cardiology market was valued at $2.6 billion in 2022 and is forecast to rise to $3.3 ...

Home May 15, 2023
Home
News | Cardiac Diagnostics

February 8, 2023 — Results of research that identified new causes of Atherosclerotic Coronary Artery Disease, or ASCAD ...

Home February 08, 2023
Home
News | Cardiac Diagnostics

September 15, 2022 - Happitech has announced the launch of its FastStart Research app. The Amsterdam-based digital ...

Home September 15, 2022
Home
Feature | Cardiac Diagnostics | by Kelly Patrick

Like most healthcare markets, the diagnostic cardiology market has had a bumpy ride in recent years. The COVID-19 ...

Home August 23, 2022
Home
Subscribe Now